Françoise Bouhour

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies

Karim Wahbi, Rabah Ben Yaou, Estelle Gandjbakhch et al. · Circulation · 2019 · 245 citations · Full text

Gender as a Modifying Factor Influencing Myotonic Dystrophy Type 1 Phenotype Severity and Mortality: A Nationwide Multiple Databases Cross-Sectional Observational Study

Céline Dogan, Marie De Antonio, Dalil Hamroun et al. · PLoS ONE · 2016 · 145 citations · Full text

[18F]Fluorodeoxyglucose positron emission tomography in the diagnosis of cancer in patients with paraneoplastic neurological syndrome and anti-Hu antibodies

J. C. Antoine, L. Cinotti, Caroline Tilikete et al. · Annals of Neurology · 2000 · 83 citations

Quantitative assessment of skeletal muscle degeneration in patients with myotonic dystrophy type 1 using MRI

Bassem Hiba, Nathalie Richard, Luc J. Hébert et al. · Journal of Magnetic Resonance Imaging · 2011 · 63 citations · Full text